Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

BSTC

BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that is focused on the development of injectable collagenase clostridium histolyticum, which has multiple indications in the United St...

BioSpecifics Technologies Corp. Annual Report 2018

Healthcare Biotechnology NASDAQ 1-10

OMER

Omeros Corp

Seattle-based Omeros Corporation, a clinical-stage biopharmaceutical firm, is making strides in the discovery, development, and commercialization of small-molecule and protein therapeutics, targeti...

Omeros Corp Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CHRS

Coherus BioSciences

California-based Coherus BioSciences, Inc. is taking the biosimilar and immuno-oncology market in the United States by storm. Specializing in the space, the biopharmaceutical company has a range of...

Coherus BioSciences Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

STSA

Satsuma Pharmaceuticals

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company based in South San Francisco, is gaining attention for its development of innovative therapeutic products for the acute tre...

Satsuma Pharmaceuticals Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

IDYA

IDEAYA Biosciences

Precision medicine oncology company, IDEAYA Biosciences, Inc., is pioneering the development of targeted therapeutics for patient populations through the use of molecular diagnostics. The company's...

IDEAYA Biosciences Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

ARDS

Aridis Pharmaceuticals Inc.

Late-stage biopharmaceutical company Aridis Pharmaceuticals, Inc. is pioneering the development of targeted immunotherapy using fully human monoclonal antibodies (mAb) for the treatment of life-thr...

Aridis Pharmaceuticals Inc. Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

CRTX

Cortexyme, Inc.

Cortexyme is a biopharmaceutical company that is focused on developing innovative therapies for patients with Alzheimer's disease and other degenerative diseases. The company's lead therapeutic can...

Cortexyme, Inc. Annual Report 2020

Healthcare Biotechnology NASDAQ 11-50

ADXN

Addex Pharmaceuticals

Addex Therapeutics Ltd, a Swiss development-stage biopharmaceutical company, is pioneering the discovery, development, and commercialization of small-molecule pharmaceutical products aimed at treat...

Addex Pharmaceuticals Annual Report 2023

Healthcare Biotechnology OTC 11-50

VBLT

Vascular Biogenics Ltd.

Vascular Biogenics Ltd, an Israeli-American biopharmaceutical firm, is dedicated to developing cutting-edge therapeutics for the treatment of major types of cancer and immune-inflammatory diseases....

Vascular Biogenics Ltd. Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

ANIK

Anika Therapeutics

Anika Therapeutics, Inc., a leading orthopedic care company, is making waves in the United States and beyond with their innovative joint preservation products. The company specializes in delivering...

Anika Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

WINT

Windtree Therapeutics, Inc.

Clinical-stage biopharmaceutical company Windtree Therapeutics, Inc. has emerged as a key player in the field of cardiovascular disease medicine. The company is focused on developing new therapeuti...

Windtree Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology OTC 51-200

EDIT

Editas Medicine

Editas Medicine, Inc. is making waves in the world of genome editing, dedicating itself to the development of transformative genomic medicines for serious diseases. Founded in 2013, the clinical st...

Editas Medicine Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

MBIO

Mustang Bio, Inc.

Massachusetts-based biopharmaceutical company, Mustang Bio Inc., is focused on developing potential cures for hematologic cancers, solid tumors, and rare genetic diseases through innovative medical...

Mustang Bio, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ANIX

Anixa Biosciences

San Jose-based biotechnology company, Anixa Biosciences, Inc., has made significant strides in the development of therapies and vaccines to address critical unmet needs in oncology and infectious d...

Anixa Biosciences Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

GENE

Genetic Technologies Ltd

Genetic Technologies Limited, a leading molecular diagnostics company, is expanding its reach to provide predictive genetic testing and risk assessment tools to physicians across multiple continent...

Genetic Technologies Ltd Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200